Ameritas Investment Partners’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Ameritas Investment Partners’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,373	Closed	-$1.37K	–	3311
2023 Q1	$1.37K	Hold	5,373	–	–	﹤0.01%	2971
2022 Q4	$6.07K	Hold	5,373	–	–	﹤0.01%	2897
2022 Q3	$10K	Buy	+5,373	New	+$9.12K	﹤0.01%	2814

Ameritas Investment Partners's PEAR Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 5,373 shares — an estimated $1.37K sold.

Ameritas Investment Partners first reported a position in PEAR in Q3 2022 and held it in 3 quarters. The position peaked at $10K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Ameritas Investment Partners reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Ameritas Investment Partners sold 5,373 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.37K.
Ameritas Investment Partners first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
Ameritas Investment Partners's Pear Therapeutics, Inc. Class A Common Stock position peaked at $10K in Q3 2022.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.